[250 Pages Report] The global organ transport devices market is set to reach a valuation of US$ 115.1 Million in 2022 and expand at a CAGR of 8.7% in the forecast period (2022-2032). The global market is projected to reach US$ 265.1 Million by the end of 2032.
| Attributes | Key Statistics |
|---|---|
| Global Organ Transport Devices Market Estimated Value (2022E) | US$ 115.1 Million |
| Projected Market Valuation (2032F) | US$ 265.1 Million |
| Value-based CAGR (2022 to 2032) | 8.7% |
| Collective Value Share: Top 5 Countries (2022E) | 55.2% |
The organ transport devices industry held approximately 51.4% of the global organ preservation market in 2021 which was worth US$ 206.1 Million.
Rising incidence of organ failure is expected to lead to increasing number of organ transplant surgeries performed around the world. Over the projected period, the market for organ transport devices is expected to grow at a fast pace due to increasing prevalence of chronic diseases.
Cardiovascular disorders, for instance, have become one of the leading causes of death and morbidity in the past three decades. According to the American Heart Association (AHA), in 2021, cardiovascular disease (CVD) affected about 92.1 million individuals in the U.S. and it is the leading cause of death in the country, as compared to other chronic conditions.
High prevalence of organ malfunction, especially of the kidney, liver, and heart, is becoming common among the geriatric population. According to the United States Government Information on Organ Donation and Transplantation, 63 per cent of those who received organ transplants in 2019 were 50 years or older, and 21% of all organ transplant patients were 65 years or older. These numbers are projected to grow rapidly in the assessment period, thereby driving demand for organ transport devices.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of organ transport devices have expanded in recent years owing to increased adoption of advanced devices and solutions. Various advantages of organ transport devices such as ease of transport and fast delivery of required organs at the right place, over other available devices in the market, is also set to push growth.
Over the forecast period, the market for organ transport devices is expected to be influenced by increased government initiatives to promote organ donation.
As per the National Kidney Foundation, at present, there are about 121,678 people waiting for lifesaving organ transplants in the U.S. Out of these, nearly 100,791 individuals are waiting for kidney transplants. Owing to the above-mentioned factors, sales of organ transport devices are projected to surge in the evaluation period.
In addition, several companies in the organ transport devices market are implementing a variety of organic strategies that would result in dynamic market improvements. They are mainly focusing on new product launches, product approvals, and development to increase sales.
For instance, TransMedics Group, Inc. received the U.S. FDA premarket approval for its OCS Liver System to preserve organs following DCD and DCBD in September 2021. The OCS Liver System would help preserve and observe metabolic and hemodynamics functions that would further enable ex-vivo assessment from DBD and DCD donor livers of liver allografts.
Spurred by the aforementioned factors, the global organ transport devices market is likely to grow at a CAGR of 8.7% from 2022 to 2032.
Governments of various countries worldwide are working to improve their healthcare infrastructures to deliver better services. Infrastructure improvement programs are set to help several hospitals to treat more brain-dead patients who may be acceptable donors.
Increasing establishment of testing laboratories and transplant centers across the globe is estimated to reduce the time spent on donor-recipient compatibility, subject profiling, genotyping, and other relevant diagnostic procedures during organ transplantations.
In addition, the industry will be boosted by increased risk of organ failure among patients suffering from chronic diseases. As per the WHO, about 34.2 million people in the U.S. are currently living with diabetes. Rising prevalence of diabetes is anticipated to result in kidney failures, thereby providing new opportunities to key players from 2022 to 2032.
Principal Consultant
Currently, there is a considerable disparity between the number of organs donated and those required. In the U.S., there were over 100,000 people on the organ transplant waiting list as of January 2022. By the end of 2021, only 41,354 transplants had been completed. The low number of organs donated each year is primarily owing to lack of organ donation awareness, ineffective legislative measures, and increased risk of organ trafficking.
Governments of various countries are also implementing reformed regulations such as opt-out laws that imply every citizen is an organ donor unless exempted and campaigns to encourage people to donate organs. However, these regulations are hampering growth in the organ transport devices market as there is a discrepancy between expected improved deceased organ donations and actual rates of deceased organ donations.
“Rising Prevalence of Organ Failure to Push the U.S. Market”
The U.S. held about 92.4% of the North America organ transport devices market share in 2021 and is expected to lead throughout the forecast period. The U.S. is considered to be the most lucrative market for organ transport devices owing to high prevalence rate of chronic disorders in the country.
Increasing cases of kidney failure in the U.S. on the back of diabetes and high blood pressure is projected to aid growth. It is further set to push the need for organ transplantation procedures and thus propel the U.S. market.
“Surging Number of Transplant Surgeries to Drive the U.K. Market”
The U.K. generated a share of approximately 20.2% in 2021 in the Europe organ transport devices market. Growth is attributed to increasing procedural rate of organ transplantation in the country.
According to the NHS 2019 Report, over 8,740 liver transplants were reported in the U.K. during the past ten years. On account of this, use of organ transport devices is projected to grow in the forthcoming years, thereby driving the U.K. market.
“Chronic Diseases among Geriatric Population to Push Growth”
China held around 57.4% share in the East Asia organ transport devices market in 2021 and is projected to grow at a rapid pace during the forecast period. Growth is attributed to increasing technological advancements in the field of organ transport in the country. Also, rising geriatric population is expected to augment growth in China.
As per the WHO, in 2019, there were 176 million older individuals belonging to the age group of 65 years or older and nearly 254 million people who were 60 years of age or older. Hence, the market for organ transport devices is expected to grow rapidly in China because of high risk of organ failure among the aging population.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Use of Hypothermic Perfusion Devices to Grow for Kidney Preservation Process”
Based on product, the cold or hypothermic perfusion devices segment is projected to showcase lucrative growth in the evaluation period. The segment held a share of 63.7% in 2021 in the global organ transport devices market.
Hypothermia is widely used and regarded as the gold standard treatment for organ preservation. Kidneys, liver, lungs, pancreas, and heart are all preserved with this method across the globe, which would push its demand in the next decade.
“Number of Kidney Transplant Surgeries to Grow in 2022-2032”
In terms of organ, the kidney segment held a revenue share of 62.0% in 2021 and is expected to grow at a considerable pace over the forecast period with a CAGR of 8.5%. Increasing number of kidney transplantation procedures across the globe with rising prevalence of chronic kidney disease and subsequent kidney failure is projected to boost the segment.
According to the CDC, chronic kidney disease affects nearly 15.0 per cent of adults in the U.S. each year. Thus, increasing number of kidney transplantation procedures is set to spur the use of novel organ transport devices.
“Transplant Centers to Adopt New Organ Transport Devices”
Based on end user, the transplant centers segment held about 67.4% of the organ transport devices market share in 2021. Increasing number of transplant centers around the world is a major factor that is projected to drive the segment. Governments of various countries are likely to invest in the enhancement of healthcare infrastructure, which would also push the segment.
Key players in the organ transport devices market are focusing on expanding their presence globally and are striving to broaden their product offerings to gain a competitive edge.
Meanwhile, some of the other companies are engaging in mergers, acquisitions, agreements, and collaborations to improve their existing product portfolios. They are also aiming to expand their manufacturing capacities to generate more shares.
Some of the recent developments in the global organ transport devices market are:
| Attributes | Details |
|---|---|
| Estimated Market Size (2022) | US$ 115.1 Million |
| Projected Market Valuation (2032) | US$ 265.1 Million |
| Value-based CAGR (2022 to 2032) | 8.7% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC countries, Turkey, and North Africa. |
| Key Market Segments Covered | Products, Organ, End User, and Region |
| Key Companies Profiled | TransMedics Inc.; Paragonix Technologies; Organ Recovery Systems; XVIVO Perfusion AB; OrganOx Limited; X-Therma Inc.; Bridge to Life; French Institut Georges Lopez (IGL); EBERS Medical Technology SL. (Spain); Vascular Perfusion Solutions (USA); tritec®; B Medical Systems; LMB Technologie GmbH |
| Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
The global organ transport devices market was worth US$ 105.9 Mn in 2021 and is set to expand 2.3x over the next ten years.
The organ transport devices market is expected to reach US$ 265.1 Mn by the end of 2032 and register a CAGR of 8.7% in 2022-2032.
Favorable government regulations, ongoing developments in the field of organ preservation devices, and growing R&D activities for the development of cost-effective services are some of the key trends shaping the organ transport devices industry.
The U.S., China, the U.K., Germany, and Japan are expected to drive demand for organ transport devices.
The U.S. accounted for nearly 92.4% of the North America organ transport devices market in 2021.
The Europe organ transport devices market is expected to register growth at a CAGR of 8.9% over the next ten years.
The U.S., Germany, and China are key producers of organ transport devices.
TransMedics Inc., Paragonix Technologies, Organ Recovery Systems, XVIVO Perfusion AB, OrganOx Limited, X-Therma Inc., Bridge to Life, and French Institut Georges Lopez (IGL) are the key organ transport devices manufacturers.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Regulatory Landscape
4.2. Pipeline Assessment
4.3. New Products Launches & Approvals
4.4. Product Adoption / Usage Analysis
4.5. Key Strategies Adopted by market players
4.6. Porter’s Analysis
4.7. PESTLE Analysis
5. COVID-19 Crisis Analysis
5.1. 2021 Market Scenario
5.2. COVID-19 and Impact Analysis
5.2.1. Revenue By Product
5.2.2. Revenue By Organ
5.2.3. Revenue By End User
5.2.4. Revenue By Country
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Spending Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Top companies’ historical growth
6.2.2. Pipeline products
6.2.3. New product launches and approvals
6.2.4. Cost of the products
6.2.5. Historic and current revenue of key players
6.2.6. Strategic developments by key players
6.2.7. New product approvals
6.2.8. Technology advancements in devices
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Organ Transport Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Volume (Units) Analysis, 2017–2021
7.2. Current and Future Market Volume (Units) (Units) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Organ Transport Devices Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Organ Transport Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2017–2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
10.3.1. Warm or Normothermic Perfusion Devices
10.3.2. Cold or Hypothermic Perfusion Devices
10.4. Market Attractiveness Analysis By Product
11. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By Organ
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Organ, 2017–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ, 2022–2032
11.3.1. Liver
11.3.2. Heart
11.3.3. Kidney
11.3.4. Lung
11.3.5. Others (pancreas, small intestine)
11.4. Market Attractiveness Analysis By Organ
12. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, By End User
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
12.3.1. Hospitals
12.3.2. Transplant Centers
12.3.3. Ambulatory Surgical Centers
12.4. Market Attractiveness Analysis By End User
13. Global Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2017–2021
13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis By Region
14. North America Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By Organ
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Organ
14.5.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. U.S. Organ Transport Devices Market
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Organ
14.9.1.2.3. By End User
14.9.2. Canada Organ Transport Devices Market
14.9.3. Introduction
14.9.4. Market Analysis and Forecast by Market Taxonomy
14.9.4.1.1. By Product
14.9.4.1.2. By Organ
14.9.4.1.3. By End User
15. Latin America Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Product
15.4.3. By Organ
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Product
15.5.2. By Organ
15.5.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. Brazil Organ Transport Devices Market
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Organ
15.9.1.2.3. By End User
15.9.2. Mexico Organ Transport Devices Market
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Organ
15.9.2.2.3. By End User
15.9.3. Argentina Organ Transport Devices Market
15.9.4. Introduction
15.9.5. Market Analysis and Forecast by Market Taxonomy
15.9.5.1.1. By Product
15.9.5.1.2. By Organ
15.9.5.1.3. By End User
16. Europe Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Product
16.4.3. By Organ
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Product
16.5.2. By Organ
16.5.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Germany Organ Transport Devices Market
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By Organ
16.9.1.2.3. By End User
16.9.2. Italy Organ Transport Devices Market
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By Organ
16.9.2.2.3. By End User
16.9.3. France Organ Transport Devices Market
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Product
16.9.3.2.2. By Organ
16.9.3.2.3. By End User
16.9.4. U.K. Organ Transport Devices Market
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Product
16.9.4.2.2. By Organ
16.9.4.2.3. By End User
16.9.5. Spain Organ Transport Devices Market
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Product
16.9.5.2.2. By Organ
16.9.5.2.3. By End User
16.9.6. BENELUX Organ Transport Devices Market
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Product
16.9.6.2.2. By Organ
16.9.6.2.3. By End User
16.9.7. Russia Organ Transport Devices Market
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Product
16.9.7.2.2. By Organ
16.9.7.2.3. By End User
17. South Asia Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Product
17.4.3. By Organ
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Product
17.5.2. By Organ
17.5.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. India Organ Transport Devices Market
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Product
17.9.1.2.2. By Organ
17.9.1.2.3. By End User
17.9.2. Thailand Organ Transport Devices Market
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Product
17.9.2.2.2. By Organ
17.9.2.2.3. By End User
17.9.3. Indonesia Organ Transport Devices Market
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Product
17.9.3.2.2. By Organ
17.9.3.2.3. By End User
17.9.4. Malaysia Organ Transport Devices Market
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast by Market Taxonomy
17.9.4.2.1. By Product
17.9.4.2.2. By Organ
17.9.4.2.3. By End User
18. East Asia Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product
18.4.3. By Organ
18.4.4. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Product
18.5.2. By Organ
18.5.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. China Organ Transport Devices Market
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Product
18.9.1.2.2. By Organ
18.9.1.2.3. By End User
18.9.2. Japan Organ Transport Devices Market
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Product
18.9.2.2.2. By Organ
18.9.2.2.3. By End User
18.9.3. South Korea Organ Transport Devices Market
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Product
18.9.3.2.2. By Organ
18.9.3.2.3. By End User
19. Oceania Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By Organ
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Product
19.5.2. By Organ
19.5.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
19.9. Country Level Analysis & Forecast
19.9.1. Australia Organ Transport Devices Market
19.9.1.1. Introduction
19.9.1.2. Market Analysis and Forecast by Market Taxonomy
19.9.1.2.1. By Product
19.9.1.2.2. By Organ
19.9.1.2.3. By End User
19.9.2. New Zealand Organ Transport Devices Market
19.9.2.1. Introduction
19.9.2.2. Market Analysis and Forecast by Market Taxonomy
19.9.2.2.1. By Product
19.9.2.2.2. By Organ
19.9.2.2.3. By End User
20. Middle East and Africa Organ Transport Devices Market Analysis 2017–2021 and Forecast 2022–2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2017–2021
20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Turkey
20.4.1.3. North Africa
20.4.1.4. South Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By Organ
20.4.4. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Product
20.5.2. By Organ
20.5.3. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. GCC Countries Organ Transport Devices Market
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Product
20.9.1.2.2. By Organ
20.9.1.2.3. By End User
20.9.2. Turkey Organ Transport Devices Market
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Product
20.9.2.2.2. By Organ
20.9.2.2.3. By End User
20.9.3. North Africa Organ Transport Devices Market
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Product
20.9.3.2.2. By Organ
20.9.3.2.3. By End User
20.9.4. South Africa Organ Transport Devices Market
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Product
20.9.4.2.2. By Organ
20.9.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of Players
21.3.2. Product foot print by Players
21.3.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. TransMedics Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Paragonix Technologies
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. Organ Recovery Systems
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. XVIVO Perfusion AB
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. OrganOx Limited
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. X-Therma Inc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Bridge to Life
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. French Institut Georges Lopez (IGL)
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
22.3.9. EBERS Medical Technology SL. (Spain)
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Product Strategy
22.3.9.6.3. Channel Strategy
22.3.10. Vascular Perfusion Solutions (US)
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Strategy Overview
22.3.10.6.1. Marketing Strategy
22.3.10.6.2. Product Strategy
22.3.10.6.3. Channel Strategy
22.3.11. tritec®
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. Key Financials
22.3.11.5. SWOT Analysis
22.3.11.6. Strategy Overview
22.3.11.6.1. Marketing Strategy
22.3.11.6.2. Product Strategy
22.3.11.6.3. Channel Strategy
22.3.12. B Medical Systems
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. Key Financials
22.3.12.5. SWOT Analysis
22.3.12.6. Strategy Overview
22.3.12.6.1. Marketing Strategy
22.3.12.6.2. Product Strategy
22.3.12.6.3. Channel Strategy
22.3.13. Lmb Technologie GmbH
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. Key Financials
22.3.13.5. SWOT Analysis
22.3.13.6. Strategy Overview
22.3.13.6.1. Marketing Strategy
22.3.13.6.2. Product Strategy
22.3.13.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Organ Transport Devices Market
